Skip to main content
. Author manuscript; available in PMC: 2020 Dec 16.
Published in final edited form as: Am J Surg Pathol. 2015 Oct;39(10):1322–1330. doi: 10.1097/PAS.0000000000000473

TABLE 3.

Distribution of Treatment for PMBL

CHOP/CHOP
Equivalent
ProMACE
All (n = 21)
 With rituximab   9 0
 Without rituximab 11 1
G-PMBL-P (n = 8)
 With rituximab   2 0
 Without rituximab   5 1
G-PMBL-M and G-PMBL-NM (n = 13)
 With rituximab   7 0
 Without rituximab   6 0

CHOP indicates cyclophosphamide, doxorubicin, vincristine, prednisone; ProMACE, prednisone, methotrexate, doxorubicin, cyclophosphamide, etoposide.